Redefining calcium modification Powered by 150 pulses

Innvolution Healthcare Pvt Ltd

Innovative IVL technology enabling safe, effective, and uniform calcium modification

Severely calcified coronary lesions remain one of the most challenging scenarios in interventional cardiology, often limiting lesion preparation and optimal stent expansion. Innvolith™, Innvolution Healthcare’s advanced Intravascular Lithotripsy (IVL) system, has been engineered to address these challenges through controlled, vessel-friendly calcium modification.

Recognized as the world’s First 150 Pulse IVL system, Innvolith delivers circumferential acoustic pressure waves that fracture both superficial and deep calcium while preserving the integrity of surrounding soft tissue. Its innovative design incorporates two emitters and three electrodes arranged in an S-shaped series, ensuring uniform energy distribution and comprehensive lesion coverage. This unique architecture enables efficient calcium fracture with fewer pulses per lesion and promotes acute luminal gain.

The system’s 360° energy emission effectively treats concentric, eccentric and nodular calcium, improving vessel compliance and facilitating optimal stent deployment. Unlike aggressive plaque modification techniques, Innvolith modifies calcium without causing vessel injury, thereby minimizing the risk of dissection and procedural complications.

Designed for procedural efficiency, Innvolith features a 12 mm treatment zone, rapid exchange platform, 6 Fr compatibility, and a broad balloon diameter matrix ranging from 2.5 mm to 4.0 mm. The hydrophilic-coated balloon enhances deliverability while ensuring smooth lesion crossing.

Combining clinical effectiveness, procedural simplicity, and enhanced safety, Innvolith represents a significant advancement in coronary calcium management. By delivering uniform lithotripsy energy with unmatched pulse capacity, it empowers physicians to confidently treat complex calcified lesions and achieve superior procedural outcomes.